Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil

International Journal of Pharmaceutics

Volumn 317, Issue 2, 2006, Pages 155-160

  Kakumanu, Vasu Kumar ^a   Arora, Vinod ^b   Bansal, Arvind K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b RANBAXY RESEARCH LABORATORIES   (India)

Author keywords

Bioavailability; Cefpodoxime proxetil; Closed loop method; Everted sac; Factors; Oral; Permeability; Reasons; Tissue uptake

Indexed keywords

CEFPODOXIME; CEFPODOXIME ACID; CEFPODOXIME PROXETIL; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG PENETRATION; DRUG TRANSPORT; DRUG UPTAKE; EX VIVO STUDY; IN VITRO STUDY; INTESTINE CELL; INTESTINE EPITHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; CEFTIZOXIME; ENTEROCYTES; HYDROGEN-ION CONCENTRATION; JEJUNUM; MALE; PRODRUGS; RATS; RATS, SPRAGUE-DAWLEY; STOMACH;

EID: 33745514646     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.03.004     Document Type: Article

References (22)

1. Borin T. A review of the pharmacokinetics of cefpodoxime proxetil. Drugs 42 (1991) 13-21
2. Crauste-Manciet S., Huneau J.F., Decroix M.O., Tome D., and Chaumeil J.C. Cefpodoxime proxetil esterase activity in rabbit small intestine: role in the partial cefpodoxime absorption. Int. J. Pharm. 149 (1997) 241-249
3. Deslandes A., Camus F., Lacroix C., Carbon C., and Farinotti R. Effects of nifedipine and diltiazem on pharmacokinetics of cefpodoxime following its oral administration. Antimicrob. Agents Chemother. 40 (1996) 2879-2881
4. Fiese G., and Perrin J.H. A note on the absorption of 3-ethoxy-N-methyl-morphinan hydrochloride from the rat stomach. J. Pharm. Pharmacol. 20 (1968) 98-101
5. Fuzimoto K., Ishihara S., Yanagisawa H., Ide J., Nakayama E., Nakao H., Sugawara S., and Iwata M. Studies on orally active cephalosporin esters. J. Antibiot. 40 (1987) 370-384
6. Gibson G.G., and Skett P. Introduction to Drug Metabolism. 2 ed. (1996), Blackie Academic & Professional, London
7. Hamamura T., Kusai A., and Nishimura K. Gel formation of cefpodoxime proxetil. S.T.P. Pharm. Sci. 5 (1995) 324-331
8. Hamamura T., Ohtani T., Kusai A., and Nishimura K. Unusual dissolution behavior of cefpodoxime proxetil: effect of pH and ionic factors. S.T.P. Pharm. Sci. 5 (1995) 332-338
9. Hamamura T., Terashima H., Ohtani T., Mori Y., Seta Y., Kusai A., Sasahara K., and Nishimura K. Decrease in dissolution of cefpodoxime proxetil tablets by gel formation and its improvement. Yakuzaigaku 55 (1995) 175-182
10. Hori R., Okano T., Kato M., Maegawa H., and Inui K. Intestinal absorption of cephalosporin antibiotics: correlation between intestinal absorption and brush-border membrane transport. J. Pharm. Pharmacol. 40 (1988) 646-647
11. Hughes G.S., Heald D.L., Barker K.B., Patel R.K., and Euler A.R. Effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil. Clin. Pharmacol. Ther. 46 (1989) 674-685
12. Inui K., Yamamoto M., and Saito H. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes. J. Pharmacol. Exp. Ther. 261 (1992) 195-201
13. Kobayashi S., Oguchi K., Uchida E., Yasuhara H., Sakamoto K., Sekine M., and Sasahara K. Phase I clinical study of CS-807, a new oral cephalosporin. Chemotherapy (Tokyo) 36 (1988) 200-214
14. Komai T., Kawai K., Tsubaki H., Tokui T., Kinoshita T., and Tanaka M. Absorption, distribution, metabolism, and excretion of CS 807, a new oral cephem antibiotic, in experimental animals. Chemotherapy (Tokyo) 36 (1988) 229-240
15. Levine R.R., and Perikan E.W. Influence of experimental procedures and dose on the intestinal absorption of an onium compound, benzomethamine. J. Pharmacol. Exp. Ther. 131 (1961) 319-327
16. Lowery O., Rosebrough N., Farr A., and Randall R. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
17. Mariappan T.T., and Singh S. Regional gastrointestinal permeability of rifampicin and isoniazid (alone and their combination) in the rat. Int. J. Tubercul. Lung Dis. 7 (2003) 797-803
18. Miyauchi M., Sasahara K., Fuzimoto K., Iwamoto I., Ide J., and Nakao H. Studies on orally active cephalosporin esters. II. Chemical stability of pivaloyloxymethyl esters in phosphate buffer solution. Chem. Pharm. Bull. 37 (1989) 2369-2374
19. Nakao H., Ide J., Yanagisawa H., Iwata M., and Hirasawa T. Cefpodoxime proxetil (CS-807), a new orally active cephalosporin. Sankyo Kenkyusho Nenpo 39 (1987) 1-44
20. Parsons D.S., and Paterson G.R. Movement of fluid and glucose in an everted sac preparation of rat colonic mucosa. Biochim. Biophys. Acta 41 (1960) 173-175
21. Peterson G.L. Review of the folin phenol protein quantification method of Lowery, Rosebrough, Farr, and Randall. Anal. Biochem. 100 (1979) 210-220
22. Wiseman G. Sac of everted intestine technic for study of intestinal absorption in vitro. Methods Med. Res. 9 (1961) 287-292